Close

Morgan Stanley Starts GW Pharma (GWPH) at Overweight on Cannabis Platform Potential

April 22, 2014 9:22 AM EDT Send to a Friend
Morgan Stanley initiated coverage on GW Pharma (NASDAQ: GWPH) with an Overweight rating and a price target of $103.00. Analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login